Education
About Us
Working with TipRanks
Follow Us
Stephanie Okey Insider Profile
4 Followers
Stephanie Okey, Director at Albireo Pharma, holds ― shares in Albireo Pharma (Ticker: ALBO), holds 13.87K shares in PTC Therapeutics (Ticker: PTCT), holds 0.00 shares in Catalent (Ticker: CTLT). Most recently, Stephanie Okey ― shares of Albireo Pharma on ― for an estimated value of ―.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+5.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephanie Okey holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 02, 2024 - Apr 02, 2025
Return:+27.60%
The most profitable trade made by Stephanie Okey
Stephanie Okey's Trading History
Albireo Pharma
―
―
―
―
PTC Therapeutics
Jan 07, 2025
Director
Uninformative Buy
―
$729.27K
Crinetics Pharmaceuticals
Jun 11, 2024
Director
Uninformative Buy
―
$312.83K
Catalent
Dec 18, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Stephanie Okey's performance on stock
You May Also Like
Stephanie Okey insider profile FAQ
What is the percentage of profitable transactions made by Stephanie Okey?
The percentage of profitable transactions made by Stephanie Okey is 67%.
What is the average return per transaction made by Stephanie Okey?
The average return per transaction made by Stephanie Okey is 5.60%.
What stocks does Stephanie Okey hold?
Stephanie Okey holds: ALBO, PTCT, CRNX, CTLT stocks.
What was Stephanie Okey’s latest transaction?
Stephanie Okey latest transaction was an Uninformative Buy of ―.
What was Stephanie Okey's most profitable transaction?
Stephanie Okey’s most profitable transaction was an Informative Sell of CRNX stock on April 2, 2024. The return on the trade was 27.60%.
What is Stephanie Okey's role in Albireo Pharma?
Stephanie Okey's role in Albireo Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.